Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:833-840

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pathak, M.
Right arrow Articles by Sen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pathak, M.
Right arrow Articles by Sen, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Other heart failure
Right arrow ACE/Angiotension receptors
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression

(Hypertension. 2001;37:833.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Role of Myocytes in Myocardial Collagen Production

Manas Pathak1; Sagartirtha Sarkar1; Elangovan Vellaichamy; Subha Sen

From the Department of Molecular Cardiology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio.

Correspondence to Subha Sen, PhD, DSc, Department of Molecular Cardiology/NB50, The Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail sens{at}ccf.org

Excessive collagen deposition may cause abnormal stiffness of the heart during hypertrophy and heart failure. The potent vasoconstrictor angiotensin II seems, via an unknown mechanism, to stimulate collagen production. This study describes the in vitro and ex vivo effects of [Sar1]Ang II on collagen production by fibroblasts in culture and in beating, nonworking heart preparations. The effects of [Sar1]Ang II on isolated rat hearts or rat heart fibroblasts were determined by quantifying transcript levels of collagen phenotypes I and III through videodensitometry after Northern blot analysis with specific cDNA probes (collagen [P {alpha} 2r2] rat {alpha} 2[I] probe for type I and human skin fibroblast {alpha}1[III] probe for type III). When [Sar1]Ang II was added in vitro to neonatal or adult 28-week-old Wistar-Kyoto rat heart fibroblasts, questionable stimulation in the mRNAs of types I and III occurred. In contrast, when 10-8 mol/L [Sar1]Ang II was added to beating, nonworking Wistar-Kyoto rat heart preparation ex vivo, a 1.5- to 2.5-fold stimulation of collagen mRNAs of phenotypes I and III was observed. When neonatal fibroblasts were cocultured with neonatal myocytes in vitro, with 10-10 mol/L [Sar1]Ang II added, there was no stimulation of either phenotype. However, significant stimulation of both collagen transcripts was recorded when 10-10 mol/L [Sar1]Ang II was added to adult fibroblasts cocultured with either neonatal or adult myocytes. Our data suggest that factors produced by myocytes are necessary for upregulation of collagen genes in vitro and demonstrate that fibroblast-myocyte cross-talk is required for Ang II–induced collagen upregulation.


Key Words: angiotensin II • cardiac myocytes • collagen • fibroblasts • hypertrophy




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Kassiri, V. Defamie, M. Hariri, G. Y. Oudit, S. Anthwal, F. Dawood, P. Liu, and R. Khokha
Simultaneous Transforming Growth Factor {beta}-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient Heart
J. Biol. Chem., October 23, 2009; 284(43): 29893 - 29904.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Burstein and S. Nattel
Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 802 - 809.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Burstein, X.-Y. Qi, Y.-H. Yeh, A. Calderone, and S. Nattel
Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: A novel consideration in atrial remodeling
Cardiovasc Res, December 1, 2007; 76(3): 442 - 452.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. K. Sen, S. Khanna, and S. Roy
Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart
Cardiovasc Res, July 15, 2006; 71(2): 280 - 288.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Camelliti, T. K. Borg, and P. Kohl
Structural and functional characterisation of cardiac fibroblasts
Cardiovasc Res, January 1, 2005; 65(1): 40 - 51.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Chen, J. L. Mehta, D. Li, L. Joseph, and J. Joseph
Transforming Growth Factor {beta} Receptor Endoglin Is Expressed in Cardiac Fibroblasts and Modulates Profibrogenic Actions of Angiotensin II
Circ. Res., December 10, 2004; 95(12): 1167 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Sarkar, E. Vellaichamy, D. Young, and S. Sen
Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H107 - H117.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Zannad, B. Dousset, and F. Alla
Treatment of Congestive Heart Failure: Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship
Hypertension, November 1, 2001; 38(5): 1227 - 1232.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. E. Dostal
Regulation of Cardiac Collagen : Angiotensin and Cross-Talk With Local Growth Factors
Hypertension, March 1, 2001; 37(3): 841 - 844.
[Full Text] [PDF]